Advert - Lilly

• Date posted
  01 November 2016
• Sanction
  Advertisement,
• Case number/s
  AUTH/2849/6/16 - Consultant oncologist and pharmacist v Lilly

For distributing a publication which included an error regarding the dose of Vitamin B12 which must be given with Alimta (pemetrexed), Lilly was ruled in breach of the following clauses of the Code:

Clause 2 - Reducing confidence in the pharmaceutical industry.

Clause 7.2 - Giving inaccurate and misleading information.

Clause 7.4 - Using unsubstantiated information.

Clause 9.1 - Failing to maintain high standards.

The full case report was published in the PMCPA November 2016 Code of Practice Review and is available at www.pmcpa.org.uk.